 | • レポートコード：QFJ1-3822 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、抗カテプシンBの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（一次抗体、タンパク質＆ペプチド、溶解物）、用途別市場規模（がん、外傷性脳損傷、エボラ感染、排卵誘発剤、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・抗カテプシンBの市場動向 ・企業の競争状況、市場シェア ・抗カテプシンBの種類別市場規模と予測2016-2027（一次抗体、タンパク質＆ペプチド、溶解物） ・抗カテプシンBの用途別市場規模と予測2016-2027（がん、外傷性脳損傷、エボラ感染、排卵誘発剤、その他） ・抗カテプシンBの北米市場規模2016-2027（アメリカ、カナダ） ・抗カテプシンBの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗カテプシンBのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗カテプシンBの中南米市場規模2016-2027（メキシコ、ブラジル） ・抗カテプシンBの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck KGaA、Bio-Techne, BioVision Inc.、Santa Cruz Biotechnology, Inc.、MedChemExpress、BioCat GmbH、ApexBio Technology、Cayman Chemical、Selleck Chemicals、BOC Sciences、AG Scientific、Virobay Inc.、Abcam Plc） ・結論 |
Cathepsin B belongs to a family of lysosomal cysteine proteases. It plays an important role in intracellular proteolysis. In humans, Cathepsin B is encoded by the CTSB gene. Anti-Cathepsin B antibody is used to treat cancers, traumatic brain injuries, Ebola infection, and fertility issues.
Market Analysis and Insights: Global Anti-Cathepsin B Market
The global Anti-Cathepsin B market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-Cathepsin B market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-Cathepsin B market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-Cathepsin B market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-Cathepsin B market.
Global Anti-Cathepsin B Scope and Market Size
Anti-Cathepsin B market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Cathepsin B market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Primary Antibodies
Proteins and Peptides
Lysates
Segment by Application
Cancer
Traumatic Brain Injury
Ebola Infection
Fertility Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck KGaA
Bio-Techne, BioVision Inc.
Santa Cruz Biotechnology, Inc.
MedChemExpress
BioCat GmbH
ApexBio Technology
Cayman Chemical
Selleck Chemicals
BOC Sciences
AG Scientific
Virobay Inc.
Abcam Plc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Cathepsin B Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Primary Antibodies
1.2.3 Proteins and Peptides
1.2.4 Lysates
1.3 Market by Application
1.3.1 Global Anti-Cathepsin B Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Traumatic Brain Injury
1.3.4 Ebola Infection
1.3.5 Fertility Treatment
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-Cathepsin B Market Perspective (2016-2027)
2.2 Anti-Cathepsin B Growth Trends by Regions
2.2.1 Anti-Cathepsin B Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-Cathepsin B Historic Market Share by Regions (2016-2021)
2.2.3 Anti-Cathepsin B Forecasted Market Size by Regions (2022-2027)
2.3 Anti-Cathepsin B Industry Dynamic
2.3.1 Anti-Cathepsin B Market Trends
2.3.2 Anti-Cathepsin B Market Drivers
2.3.3 Anti-Cathepsin B Market Challenges
2.3.4 Anti-Cathepsin B Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Cathepsin B Players by Revenue
3.1.1 Global Top Anti-Cathepsin B Players by Revenue (2016-2021)
3.1.2 Global Anti-Cathepsin B Revenue Market Share by Players (2016-2021)
3.2 Global Anti-Cathepsin B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-Cathepsin B Revenue
3.4 Global Anti-Cathepsin B Market Concentration Ratio
3.4.1 Global Anti-Cathepsin B Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Cathepsin B Revenue in 2020
3.5 Anti-Cathepsin B Key Players Head office and Area Served
3.6 Key Players Anti-Cathepsin B Product Solution and Service
3.7 Date of Enter into Anti-Cathepsin B Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Cathepsin B Breakdown Data by Type
4.1 Global Anti-Cathepsin B Historic Market Size by Type (2016-2021)
4.2 Global Anti-Cathepsin B Forecasted Market Size by Type (2022-2027)
5 Anti-Cathepsin B Breakdown Data by Application
5.1 Global Anti-Cathepsin B Historic Market Size by Application (2016-2021)
5.2 Global Anti-Cathepsin B Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anti-Cathepsin B Market Size (2016-2027)
6.2 North America Anti-Cathepsin B Market Size by Type
6.2.1 North America Anti-Cathepsin B Market Size by Type (2016-2021)
6.2.2 North America Anti-Cathepsin B Market Size by Type (2022-2027)
6.2.3 North America Anti-Cathepsin B Market Size by Type (2016-2027)
6.3 North America Anti-Cathepsin B Market Size by Application
6.3.1 North America Anti-Cathepsin B Market Size by Application (2016-2021)
6.3.2 North America Anti-Cathepsin B Market Size by Application (2022-2027)
6.3.3 North America Anti-Cathepsin B Market Size by Application (2016-2027)
6.4 North America Anti-Cathepsin B Market Size by Country
6.4.1 North America Anti-Cathepsin B Market Size by Country (2016-2021)
6.4.2 North America Anti-Cathepsin B Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-Cathepsin B Market Size (2016-2027)
7.2 Europe Anti-Cathepsin B Market Size by Type
7.2.1 Europe Anti-Cathepsin B Market Size by Type (2016-2021)
7.2.2 Europe Anti-Cathepsin B Market Size by Type (2022-2027)
7.2.3 Europe Anti-Cathepsin B Market Size by Type (2016-2027)
7.3 Europe Anti-Cathepsin B Market Size by Application
7.3.1 Europe Anti-Cathepsin B Market Size by Application (2016-2021)
7.3.2 Europe Anti-Cathepsin B Market Size by Application (2022-2027)
7.3.3 Europe Anti-Cathepsin B Market Size by Application (2016-2027)
7.4 Europe Anti-Cathepsin B Market Size by Country
7.4.1 Europe Anti-Cathepsin B Market Size by Country (2016-2021)
7.4.2 Europe Anti-Cathepsin B Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti-Cathepsin B Market Size (2016-2027)
8.2 Asia-Pacific Anti-Cathepsin B Market Size by Type
8.2.1 Asia-Pacific Anti-Cathepsin B Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-Cathepsin B Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-Cathepsin B Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-Cathepsin B Market Size by Application
8.3.1 Asia-Pacific Anti-Cathepsin B Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-Cathepsin B Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-Cathepsin B Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-Cathepsin B Market Size by Region
8.4.1 Asia-Pacific Anti-Cathepsin B Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-Cathepsin B Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-Cathepsin B Market Size (2016-2027)
9.2 Latin America Anti-Cathepsin B Market Size by Type
9.2.1 Latin America Anti-Cathepsin B Market Size by Type (2016-2021)
9.2.2 Latin America Anti-Cathepsin B Market Size by Type (2022-2027)
9.2.3 Latin America Anti-Cathepsin B Market Size by Type (2016-2027)
9.3 Latin America Anti-Cathepsin B Market Size by Application
9.3.1 Latin America Anti-Cathepsin B Market Size by Application (2016-2021)
9.3.2 Latin America Anti-Cathepsin B Market Size by Application (2022-2027)
9.3.3 Latin America Anti-Cathepsin B Market Size by Application (2016-2027)
9.4 Latin America Anti-Cathepsin B Market Size by Country
9.4.1 Latin America Anti-Cathepsin B Market Size by Country (2016-2021)
9.4.2 Latin America Anti-Cathepsin B Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Cathepsin B Market Size (2016-2027)
10.2 Middle East & Africa Anti-Cathepsin B Market Size by Type
10.2.1 Middle East & Africa Anti-Cathepsin B Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-Cathepsin B Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-Cathepsin B Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-Cathepsin B Market Size by Application
10.3.1 Middle East & Africa Anti-Cathepsin B Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-Cathepsin B Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-Cathepsin B Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-Cathepsin B Market Size by Country
10.4.1 Middle East & Africa Anti-Cathepsin B Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-Cathepsin B Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Anti-Cathepsin B Introduction
11.1.4 Merck KGaA Revenue in Anti-Cathepsin B Business (2016-2021)
11.1.5 Merck KGaA Recent Development
11.2 Bio-Techne, BioVision Inc.
11.2.1 Bio-Techne, BioVision Inc. Company Details
11.2.2 Bio-Techne, BioVision Inc. Business Overview
11.2.3 Bio-Techne, BioVision Inc. Anti-Cathepsin B Introduction
11.2.4 Bio-Techne, BioVision Inc. Revenue in Anti-Cathepsin B Business (2016-2021)
11.2.5 Bio-Techne, BioVision Inc. Recent Development
11.3 Santa Cruz Biotechnology, Inc.
11.3.1 Santa Cruz Biotechnology, Inc. Company Details
11.3.2 Santa Cruz Biotechnology, Inc. Business Overview
11.3.3 Santa Cruz Biotechnology, Inc. Anti-Cathepsin B Introduction
11.3.4 Santa Cruz Biotechnology, Inc. Revenue in Anti-Cathepsin B Business (2016-2021)
11.3.5 Santa Cruz Biotechnology, Inc. Recent Development
11.4 MedChemExpress
11.4.1 MedChemExpress Company Details
11.4.2 MedChemExpress Business Overview
11.4.3 MedChemExpress Anti-Cathepsin B Introduction
11.4.4 MedChemExpress Revenue in Anti-Cathepsin B Business (2016-2021)
11.4.5 MedChemExpress Recent Development
11.5 BioCat GmbH
11.5.1 BioCat GmbH Company Details
11.5.2 BioCat GmbH Business Overview
11.5.3 BioCat GmbH Anti-Cathepsin B Introduction
11.5.4 BioCat GmbH Revenue in Anti-Cathepsin B Business (2016-2021)
11.5.5 BioCat GmbH Recent Development
11.6 ApexBio Technology
11.6.1 ApexBio Technology Company Details
11.6.2 ApexBio Technology Business Overview
11.6.3 ApexBio Technology Anti-Cathepsin B Introduction
11.6.4 ApexBio Technology Revenue in Anti-Cathepsin B Business (2016-2021)
11.6.5 ApexBio Technology Recent Development
11.7 Cayman Chemical
11.7.1 Cayman Chemical Company Details
11.7.2 Cayman Chemical Business Overview
11.7.3 Cayman Chemical Anti-Cathepsin B Introduction
11.7.4 Cayman Chemical Revenue in Anti-Cathepsin B Business (2016-2021)
11.7.5 Cayman Chemical Recent Development
11.8 Selleck Chemicals
11.8.1 Selleck Chemicals Company Details
11.8.2 Selleck Chemicals Business Overview
11.8.3 Selleck Chemicals Anti-Cathepsin B Introduction
11.8.4 Selleck Chemicals Revenue in Anti-Cathepsin B Business (2016-2021)
11.8.5 Selleck Chemicals Recent Development
11.9 BOC Sciences
11.9.1 BOC Sciences Company Details
11.9.2 BOC Sciences Business Overview
11.9.3 BOC Sciences Anti-Cathepsin B Introduction
11.9.4 BOC Sciences Revenue in Anti-Cathepsin B Business (2016-2021)
11.9.5 BOC Sciences Recent Development
11.10 AG Scientific
11.10.1 AG Scientific Company Details
11.10.2 AG Scientific Business Overview
11.10.3 AG Scientific Anti-Cathepsin B Introduction
11.10.4 AG Scientific Revenue in Anti-Cathepsin B Business (2016-2021)
11.10.5 AG Scientific Recent Development
11.11 Virobay Inc.
11.11.1 Virobay Inc. Company Details
11.11.2 Virobay Inc. Business Overview
11.11.3 Virobay Inc. Anti-Cathepsin B Introduction
11.11.4 Virobay Inc. Revenue in Anti-Cathepsin B Business (2016-2021)
11.11.5 Virobay Inc. Recent Development
11.12 Abcam Plc
11.12.1 Abcam Plc Company Details
11.12.2 Abcam Plc Business Overview
11.12.3 Abcam Plc Anti-Cathepsin B Introduction
11.12.4 Abcam Plc Revenue in Anti-Cathepsin B Business (2016-2021)
11.12.5 Abcam Plc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anti-Cathepsin B Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Primary Antibodies
Table 3. Key Players of Proteins and Peptides
Table 4. Key Players of Lysates
Table 5. Global Anti-Cathepsin B Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti-Cathepsin B Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anti-Cathepsin B Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Anti-Cathepsin B Market Share by Regions (2016-2021)
Table 9. Global Anti-Cathepsin B Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Anti-Cathepsin B Market Share by Regions (2022-2027)
Table 11. Anti-Cathepsin B Market Trends
Table 12. Anti-Cathepsin B Market Drivers
Table 13. Anti-Cathepsin B Market Challenges
Table 14. Anti-Cathepsin B Market Restraints
Table 15. Global Anti-Cathepsin B Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Anti-Cathepsin B Market Share by Players (2016-2021)
Table 17. Global Top Anti-Cathepsin B Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Cathepsin B as of 2020)
Table 18. Ranking of Global Top Anti-Cathepsin B Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Anti-Cathepsin B Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Anti-Cathepsin B Product Solution and Service
Table 22. Date of Enter into Anti-Cathepsin B Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-Cathepsin B Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Anti-Cathepsin B Revenue Market Share by Type (2016-2021)
Table 26. Global Anti-Cathepsin B Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Anti-Cathepsin B Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Anti-Cathepsin B Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Anti-Cathepsin B Revenue Market Share by Application (2016-2021)
Table 30. Global Anti-Cathepsin B Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Anti-Cathepsin B Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Anti-Cathepsin B Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Anti-Cathepsin B Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Anti-Cathepsin B Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Anti-Cathepsin B Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Anti-Cathepsin B Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Anti-Cathepsin B Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Anti-Cathepsin B Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Anti-Cathepsin B Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Anti-Cathepsin B Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Anti-Cathepsin B Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Anti-Cathepsin B Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Anti-Cathepsin B Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Anti-Cathepsin B Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Anti-Cathepsin B Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Anti-Cathepsin B Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Anti-Cathepsin B Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anti-Cathepsin B Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Anti-Cathepsin B Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Anti-Cathepsin B Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Anti-Cathepsin B Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Anti-Cathepsin B Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Anti-Cathepsin B Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Anti-Cathepsin B Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Anti-Cathepsin B Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Anti-Cathepsin B Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Anti-Cathepsin B Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Anti-Cathepsin B Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Anti-Cathepsin B Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anti-Cathepsin B Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Anti-Cathepsin B Market Size by Country (2022-2027) & (US$ Million)
Table 62. Merck KGaA Company Details
Table 63. Merck KGaA Business Overview
Table 64. Merck KGaA Anti-Cathepsin B Product
Table 65. Merck KGaA Revenue in Anti-Cathepsin B Business (2016-2021) & (US$ Million)
Table 66. Merck KGaA Recent Development
Table 67. Bio-Techne, BioVision Inc. Company Details
Table 68. Bio-Techne, BioVision Inc. Business Overview
Table 69. Bio-Techne, BioVision Inc. Anti-Cathepsin B Product
Table 70. Bio-Techne, BioVision Inc. Revenue in Anti-Cathepsin B Business (2016-2021) & (US$ Million)
Table 71. Bio-Techne, BioVision Inc. Recent Development
Table 72. Santa Cruz Biotechnology, Inc. Company Details
Table 73. Santa Cruz Biotechnology, Inc. Business Overview
Table 74. Santa Cruz Biotechnology, Inc. Anti-Cathepsin B Product
Table 75. Santa Cruz Biotechnology, Inc. Revenue in Anti-Cathepsin B Business (2016-2021) & (US$ Million)
Table 76. Santa Cruz Biotechnology, Inc. Recent Development
Table 77. MedChemExpress Company Details
Table 78. MedChemExpress Business Overview
Table 79. MedChemExpress Anti-Cathepsin B Product
Table 80. MedChemExpress Revenue in Anti-Cathepsin B Business (2016-2021) & (US$ Million)
Table 81. MedChemExpress Recent Development
Table 82. BioCat GmbH Company Details
Table 83. BioCat GmbH Business Overview
Table 84. BioCat GmbH Anti-Cathepsin B Product
Table 85. BioCat GmbH Revenue in Anti-Cathepsin B Business (2016-2021) & (US$ Million)
Table 86. BioCat GmbH Recent Development
Table 87. ApexBio Technology Company Details
Table 88. ApexBio Technology Business Overview
Table 89. ApexBio Technology Anti-Cathepsin B Product
Table 90. ApexBio Technology Revenue in Anti-Cathepsin B Business (2016-2021) & (US$ Million)
Table 91. ApexBio Technology Recent Development
Table 92. Cayman Chemical Company Details
Table 93. Cayman Chemical Business Overview
Table 94. Cayman Chemical Anti-Cathepsin B Product
Table 95. Cayman Chemical Revenue in Anti-Cathepsin B Business (2016-2021) & (US$ Million)
Table 96. Cayman Chemical Recent Development
Table 97. Selleck Chemicals Company Details
Table 98. Selleck Chemicals Business Overview
Table 99. Selleck Chemicals Revenue in Anti-Cathepsin B Business (2016-2021) & (US$ Million)
Table 100. Selleck Chemicals Recent Development
Table 101. BOC Sciences Company Details
Table 102. BOC Sciences Business Overview
Table 103. BOC Sciences Anti-Cathepsin B Product
Table 104. BOC Sciences Revenue in Anti-Cathepsin B Business (2016-2021) & (US$ Million)
Table 105. BOC Sciences Recent Development
Table 106. AG Scientific Company Details
Table 107. AG Scientific Business Overview
Table 108. AG Scientific Anti-Cathepsin B Product
Table 109. AG Scientific Revenue in Anti-Cathepsin B Business (2016-2021) & (US$ Million)
Table 110. AG Scientific Recent Development
Table 111. Virobay Inc. Company Details
Table 112. Virobay Inc. Business Overview
Table 113. Virobay Inc. Anti-Cathepsin B Product
Table 114. Virobay Inc. Revenue in Anti-Cathepsin B Business (2016-2021) & (US$ Million)
Table 115. Virobay Inc. Recent Development
Table 116. Abcam Plc Company Details
Table 117. Abcam Plc Business Overview
Table 118. Abcam Plc Anti-Cathepsin B Product
Table 119. Abcam Plc Revenue in Anti-Cathepsin B Business (2016-2021) & (US$ Million)
Table 120. Abcam Plc Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Cathepsin B Market Share by Type: 2020 VS 2027
Figure 2. Primary Antibodies Features
Figure 3. Proteins and Peptides Features
Figure 4. Lysates Features
Figure 5. Global Anti-Cathepsin B Market Share by Application: 2020 VS 2027
Figure 6. Cancer Case Studies
Figure 7. Traumatic Brain Injury Case Studies
Figure 8. Ebola Infection Case Studies
Figure 9. Fertility Treatment Case Studies
Figure 10. Others Case Studies
Figure 11. Anti-Cathepsin B Report Years Considered
Figure 12. Global Anti-Cathepsin B Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Anti-Cathepsin B Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Anti-Cathepsin B Market Share by Regions: 2020 VS 2027
Figure 15. Global Anti-Cathepsin B Market Share by Regions (2022-2027)
Figure 16. Global Anti-Cathepsin B Market Share by Players in 2020
Figure 17. Global Top Anti-Cathepsin B Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Cathepsin B as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Anti-Cathepsin B Revenue in 2020
Figure 19. Global Anti-Cathepsin B Revenue Market Share by Type (2016-2021)
Figure 20. Global Anti-Cathepsin B Revenue Market Share by Type (2022-2027)
Figure 21. North America Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Anti-Cathepsin B Market Share by Type (2016-2027)
Figure 23. North America Anti-Cathepsin B Market Share by Application (2016-2027)
Figure 24. North America Anti-Cathepsin B Market Share by Country (2016-2027)
Figure 25. United States Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Anti-Cathepsin B Market Share by Type (2016-2027)
Figure 29. Europe Anti-Cathepsin B Market Share by Application (2016-2027)
Figure 30. Europe Anti-Cathepsin B Market Share by Country (2016-2027)
Figure 31. Germany Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Anti-Cathepsin B Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Anti-Cathepsin B Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Anti-Cathepsin B Market Share by Region (2016-2027)
Figure 41. China Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Anti-Cathepsin B Market Share by Type (2016-2027)
Figure 49. Latin America Anti-Cathepsin B Market Share by Application (2016-2027)
Figure 50. Latin America Anti-Cathepsin B Market Share by Country (2016-2027)
Figure 51. Mexico Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Anti-Cathepsin B Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Anti-Cathepsin B Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Anti-Cathepsin B Market Share by Country (2016-2027)
Figure 57. Turkey Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Anti-Cathepsin B Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Merck KGaA Revenue Growth Rate in Anti-Cathepsin B Business (2016-2021)
Figure 61. Bio-Techne, BioVision Inc. Revenue Growth Rate in Anti-Cathepsin B Business (2016-2021)
Figure 62. Santa Cruz Biotechnology, Inc. Revenue Growth Rate in Anti-Cathepsin B Business (2016-2021)
Figure 63. MedChemExpress Revenue Growth Rate in Anti-Cathepsin B Business (2016-2021)
Figure 64. BioCat GmbH Revenue Growth Rate in Anti-Cathepsin B Business (2016-2021)
Figure 65. ApexBio Technology Revenue Growth Rate in Anti-Cathepsin B Business (2016-2021)
Figure 66. Cayman Chemical Revenue Growth Rate in Anti-Cathepsin B Business (2016-2021)
Figure 67. Selleck Chemicals Revenue Growth Rate in Anti-Cathepsin B Business (2016-2021)
Figure 68. BOC Sciences Revenue Growth Rate in Anti-Cathepsin B Business (2016-2021)
Figure 69. AG Scientific Revenue Growth Rate in Anti-Cathepsin B Business (2016-2021)
Figure 70. Virobay Inc. Revenue Growth Rate in Anti-Cathepsin B Business (2016-2021)
Figure 71. Abcam Plc Revenue Growth Rate in Anti-Cathepsin B Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
外傷性脳損傷診断のグローバル市場：規模・現状・予測2019-2025 The global Traumatic Brain Injury Diagnostic Market Size will reach 161.86 million US$ in 2025, from 37.51 million US$ in 2018, with a CAGR of 23.10% during the forecast period. This report focuses on the global Traumatic Brain Injury Diagnostic status, future forecast, growth opportunity, key marke…- 外傷性脳損傷診断のグローバル市場：規模・現状・予測2019-2025 The global Traumatic Brain Injury Diagnostic Market Size will reach 161.86 million US$ in 2025, from 37.51 million US$ in 2018, with a CAGR of 23.10% during the forecast period. This report focuses on the global Traumatic Brain Injury Diagnostic status, future forecast, growth opportunity, key marke…
- 外傷性脳損傷治療薬のグローバル市場調査 2019年 The global Traumatic Brain Injury Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Traumatic Brain Injury Therapeutics volume and value at global level, regional level and company level.…
- 外傷性脳損傷治療薬のグローバル市場調査 2019年 The global Traumatic Brain Injury Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Traumatic Brain Injury Therapeutics volume and value at global level, regional level and company level.…
- 世界の注射式しわ治療市場規模・現状・予測（2021年-2027年） Injectable anti –wrinkle are the treatment that are injected into the treatment area to reduce the skin lines and wrinkles. It can also fill the sagging skin and tighten the skin, reduce the frown lines, and lines under the eyes etc. The injectable anti-wrinkle treatment can help in rejuvenation of …